+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07189936

Study of 2-HOBA Treatment to Reduce Immune Activation and Improve Symptoms in Long COVID Patients with Postural Tachycardia Syndrome POTS

Led by Vanderbilt University Medical Center · Updated on 2026-01-22

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying Long COVID Postural Orthostatic Tachycardia Syndrome LCPOTS, a condition where symptoms like fatigue, exercise intolerance, and rapid heartbeat upon standing last for more than three months after a COVID-19 infection. This study aims to evaluate the effects of 2-hydroxybenzylamine 2-HOBA, a substance that targets harmful immune markers called IsoLG-adducts, by comparing it with a placebo in people with LCPOTS. The study focuses on understanding persistent immune activation and related symptoms in this condition. Participants will be randomly assigned to receive either 2-HOBA or a placebo for 28 days. The 2-HOBA treatment is given as a 500 mg dose three times daily. The study involves three in-person visits and one telemedicine visit, during which researchers will measure immune markers, inflammatory cytokines, splanchnic venous capacitance, and orthostatic tachycardia. The trial uses tests like 30-minute head-up tilt to assess changes caused by the treatment. During the study, participants will have blood tests to measure immune cell complexes and inflammatory signals, as well as assessments of blood flow and heart rate responses to posture changes. Researchers will track these outcomes before and after the 28-day treatment period. Safety monitoring will include tracking any adverse effects and reviewing data quality regularly. The study plans to enroll a total of 50 participants and will maintain privacy through coded data storage.

CONDITIONS

Brief Title

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

Research Team

M

Marwa Mohamed, PhD

C

Cyndya Shibao, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here